Furthermore, it mitigated insulin resistance by upregulating the expression of insulin‐sensitive factors, such as GLUT4 and IRS2, while concurrently downregulating insulin resistance factors, including PTP1B and SOCS3 (Figure 3F). The gene discussed is IRS2; the disease is Insulin resistance.